Now that ELTP is on the radar expect a few upgrades expect a few upgrades, and here is WHY (IMHO):
1. New products on line new revenue will reduce, recouping costs at a greater pace.
2. At $0.16 current PE is 15.0 while S&P 500 is at 17.5.
a. This translates to $0.19 short-term target.
3. S&P’s revised 12 month Profit Margin is now +43.8% S&P 500’s is +7.09%
a. This translates to $0.90 near term price target (IMHO by next quarter)
4. ELTP’s peers:
a. BPTH with no PE, no Profit Margin closed at $0.77
b. OCRX with no PE, no Profit Margin closed at $8.71
c. ORMP with no PE, no Profit Margin closed at $6.53
d. TSPT with no PE, -125.2% Profit Margin closed at $3.74
5. Where do you think ELTP’s price will close EOM or after next quarter’s results.
As the numbers show I’m betting we'll see over $0.77 soon - plus $8.71 is out there too (that’s wish full thinking). I’m adding to dips.
Good luck longs
you are forgetting one thing ... this company has no products .. generic BS... it is all a show they have been releasing new products for the last 3 years and the stock goes up and then down and stuck at .6 for years
there is a reason for this - they have nothing
if they had something the price would of moved up a long time ago - you can not compare this with other bio tech